In Vitro Diagnostics market Was Valued At USD 46.0 Billion In 2011 And Is Expected To Reach An Estimated Value Of USD 74.2 Billion In 2018

In Vitro Diagnostics market Was Valued At USD 46.0 Billion In 2011 And Is Expected To Reach An Estimated Value Of USD 74.2 Billion In 2018

Transparency Market Research

Transparency Market Research published new market report “In Vitro Diagnostics Market (Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics)- Global Industry Analysis, Size, Share, Growth and Forecast, 2012 – 2018,” market was valued at USD 46.0 billion in 2011 and is expected to reach an estimated value of USD 74.2 billion in 2018, growing at a CAGR of 7.1% from 2012 to 2018.

Browse the full report with TOC athttp://www.transparencymarketresearch.com/in-vitro-diagnostic-tests.html

In vitro diagnostics (IVDs) provide valuable information regarding the physiological and/or pathological state of body and therefore are very essential to take well-informed medical decisions. Rising number of patients suffering from infectious and chronic diseases such as sexually transmitted diseases, chronic obstructive pulmonary disease, diabetes and cancer is the most significant growth driver of this market. In addition, factors such as increasing global healthcare expenditure and demand for rapid, minimally invasive and non-invasive diagnostic tools & techniques are driving the market as well.

In 2011, the North America IVD market held the second largest share of the global market at approximately 40%. The Asia-Pacific IVD market is expected to outperform all geographies in terms of growth rate during the forecast period. Presence of large patient pool and rising healthcare expenditure in these regions are responsible for this growth.

The clinical chemistry segment of the market held the largest market share across all major geographic regions such as the U.S., China and India in 2011. However, increase in demand for molecular diagnostics in the IVD market is expected to cut into the market share of clinical chemistry by 2018.

Browse the full report PDF With TOC at In Vitro Diagnostics Market – Global Industry Analysis, Size, Share, Growth and Forecast, 2012 – 2018

In 2011, Roche Diagnostics (Roche Group) held the largest share in the global in vitro diagnostics market followed by Siemens Healthcare (Siemens AG). Some of the other major companies involved in the development, manufacturing and distribution of in vitro diagnostics are Johnson & Johnson, Beckman Coulter Inc., Becton Dickinson and Company, Gen-Probe Incorporated and Thermo Fisher Scientific Corporation.

The global in vitro diagnostics market is categorized into the following segments:

Market by Products

  • U.S.
    • Clinical Chemistry
    • Immunoassay
    • Diabetes Testing
    • Blood Testing
    • Molecular Diagnostics
    • Others (Flow Cytometry, Microbiological Diagnostic Techniques)
  • India
    • Clinical Chemistry
    • Immunoassay
    • Diabetes Testing
    • Blood Testing
    • Molecular Diagnostics
    • Others (Flow Cytometry, Microbiological Diagnostic Techniques)
  • China
    • Clinical Chemistry
    • Immunoassay
    • Diabetes Testing
    • Blood Testing
    • Molecular Diagnostics
    • Others (Flow Cytometry, Microbiological Diagnostic Techniques)

Market by Geography

    • North America
    • Europe
    • Asia-Pacific
    • Rest of the World (RoW)
Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s